A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer

NCT02163694 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

513

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Veliparib Placebo
DRUG: Veliparib
DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

AbbVie